New Roadside Drug Testing Regimen Launches in Wellington, Expanding Nationally in 2026
Table of Contents
Police in New Zealand are implementing a comprehensive new roadside drug testing program, beginning Monday in the Wellington District. The initiative, utilizing advanced oral-fluid testing devices, aims to deter drug-impaired driving and enhance road safety across the country.
The new system empowers police to stop any vehicle and screen drivers for the presence of four key drugs: THC (cannabis), methamphetamine (meth), MDMA (ecstasy), and cocaine. Nationwide rollout is planned for April 2026, with full coverage anticipated by mid-2026.
Targeting Impairment, Not Just Presence
According to a senior official, the testing regime is designed to identify recent drug use that demonstrably impairs driving ability, rather than detecting historical use or accidental exposure. “Similar to testing for alcohol levels, there are thresholds for each drug that are set to indicate recent use…which would be unlikely to cause impairment,” the official stated.
Alongside the new roadside testing, police will continue to employ the Compulsory Impairment Test (CIT), a behavioral assessment used when officers have reasonable suspicion of impairment.
Prescriptions and Medical Defenses
Drivers currently taking prescribed medication are advised to continue their treatment as directed by their healthcare provider, but to carefully consider any potential impairing effects. “Ultimately, responsibility remains with drivers to consult their practitioner for medical advice,” the official emphasized. “If they are experiencing any impairing effects, they should not drive.”
Importantly, drivers will not be able to avoid testing or dispute a positive initial result by presenting a prescription or medical note at the roadside. However, individuals issued an infringement notice following laboratory confirmation of drug use will have the opportunity to apply for a medical defense if the drug was legitimately prescribed. Information on this process will be available on the police website starting Monday.
Penalties for Non-Compliance and Positive Tests
Refusal to comply with a roadside drug screening test carries significant consequences. Drivers who refuse or fail a test will face an infringement notice including a $400 fine, 75 license demerit points, and a 12-hour driving prohibition.
A positive laboratory result will also result in an infringement notice. The message from authorities is unequivocal: “The message is clear to drivers who blatantly drive impaired by drugs – don’t take drugs and drive.”
How the Roadside Testing Works
The initial screening process involves a quick tongue swipe, taking only a few minutes to complete. Drivers receiving a negative result will typically be free to proceed within approximately five minutes.
A positive initial test triggers a follow-up procedure: a saliva sample will be collected for more comprehensive laboratory analysis. While the roadside device screens for four specific drugs, the laboratory is capable of testing for up to 25 substances.
Following a positive second roadside screening test, drivers will be prohibited from driving for 12 hours to mitigate immediate road safety risks.
Authorities underscore the severity of the issue, citing the “devastating impact of fatal crashes due to drug driving and the flow on effects it has caused families and communities.” They assure the public that those who choose to drive under the influence of impairing drugs “will be caught.”
